14-75084551-C-T
Position:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_033116.6(NEK9):c.*13G>A variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.987 in 152,346 control chromosomes in the GnomAD database, including 74,204 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.99 ( 74204 hom., cov: 32)
Exomes 𝑓: 1.0 ( 728886 hom. )
Failed GnomAD Quality Control
Consequence
NEK9
NM_033116.6 3_prime_UTR
NM_033116.6 3_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: -1.70
Genes affected
NEK9 (HGNC:18591): (NIMA related kinase 9) This gene encodes a member of the NimA (never in mitosis A) family of serine/threonine protein kinases. The encoded protein is activated in mitosis and, in turn, activates other family members during mitosis. This protein also mediates cellular processes that are essential for interphase progression. [provided by RefSeq, Jul 2016]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.8).
BP6
Variant 14-75084551-C-T is Benign according to our data. Variant chr14-75084551-C-T is described in ClinVar as [Benign]. Clinvar id is 1325899.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.994 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NEK9 | NM_033116.6 | c.*13G>A | 3_prime_UTR_variant | 22/22 | ENST00000238616.10 | NP_149107.4 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NEK9 | ENST00000238616 | c.*13G>A | 3_prime_UTR_variant | 22/22 | 1 | NM_033116.6 | ENSP00000238616.5 |
Frequencies
GnomAD3 genomes AF: 0.987 AC: 150223AN: 152228Hom.: 74146 Cov.: 32
GnomAD3 genomes
AF:
AC:
150223
AN:
152228
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.997 AC: 250556AN: 251396Hom.: 124876 AF XY: 0.998 AC XY: 135531AN XY: 135864
GnomAD3 exomes
AF:
AC:
250556
AN:
251396
Hom.:
AF XY:
AC XY:
135531
AN XY:
135864
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome Data not reliable, filtered out with message: AS_VQSR AF: 0.999 AC: 1459700AN: 1461708Hom.: 728886 Cov.: 43 AF XY: 0.999 AC XY: 726309AN XY: 727160
GnomAD4 exome
Data not reliable, filtered out with message: AS_VQSR
AF:
AC:
1459700
AN:
1461708
Hom.:
Cov.:
43
AF XY:
AC XY:
726309
AN XY:
727160
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.987 AC: 150340AN: 152346Hom.: 74204 Cov.: 32 AF XY: 0.987 AC XY: 73550AN XY: 74498
GnomAD4 genome
AF:
AC:
150340
AN:
152346
Hom.:
Cov.:
32
AF XY:
AC XY:
73550
AN XY:
74498
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
3472
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Arthrogryposis, Perthes disease, and upward gaze palsy Benign:1
Benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Sep 05, 2021 | - - |
not provided Benign:1
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
NEK9-related lethal skeletal dysplasia Benign:1
Benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Sep 05, 2021 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at